Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.304ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.315ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.198ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.366ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.441ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.416ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.63ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.263ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.135ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DR.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.516ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.354ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.162ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.426ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.402ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.424ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.264ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.581ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.330ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.205ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.177ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.301ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.308ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.210ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.325ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.590ENiu-ECACGTTAACAATATTGCAGC20402639126372R-16283.8China
B.1.116ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.496ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.438.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.49 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.507ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.178ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.273ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.211ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.474ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.297ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AH.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.280ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.597ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.100ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.43.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EU.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.48ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used